HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients.

Abstract
The purpose of this study was to characterize the clinical and serological features of a large cohort of patients with antinuclear antibody (ANA) positive undifferentiated connective tissue disease (UCTD). Consecutive patients with UCTD, followed up at the Rheumatology Clinic of the participating centers, were included. Data from these patients were obtained by clinical evaluation and chart review. All patients were diagnosed as having UCTD on basis of the following criteria: positive ANA plus at least one clinical feature of connective tissue disease, but not fulfilling classification criteria for any differentiated connective tissue disease. One hundred eighty-four patients were studied (female patients-94.5%; mean age at time of evaluation-47 years). The most prevalent manifestations were arthralgia (66%), arthritis (32%), Raynaud's phenomenon (30%), sicca symptoms (30%), and leukopenia (19%). The prevalence of ANA was 100%, anti-SSA 20%, anti-dsDNA 14%, and anti-SSB 7%. Patients with anti-dsDNA/anti-Sm, anticentromere/anti-Scl70, or anti-SSA/anti-SSB antibodies more frequently presented a set of manifestations close to systemic lupus erythematosus (SLE), systemic sclerosis, or Sjögren syndrome, respectively. We analyze a large cohort of UCTD. Seventy-two percent of these UCTD patients present lupus-, scleroderma-, or Sjögren-like features but do not fulfill classification criteria and mostly present a mild disease.
AuthorsC C Vaz, M Couto, D Medeiros, L Miranda, J Costa, P Nero, R Barros, M J Santos, E Sousa, A Barcelos, L Inês
JournalClinical rheumatology (Clin Rheumatol) Vol. 28 Issue 8 Pg. 915-21 (Aug 2009) ISSN: 1434-9949 [Electronic] Germany
PMID19390908 (Publication Type: Journal Article, Multicenter Study)
Chemical References
  • Antibodies, Antinuclear
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Antinuclear (blood)
  • Connective Tissue Diseases (blood, classification, diagnosis)
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Lupus Erythematosus, Systemic (blood)
  • Middle Aged
  • Prognosis
  • Scleroderma, Systemic (blood)
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: